Literature DB >> 17021247

Use of the immunodominant 18-kiloDalton small heat shock protein as a serological marker for exposure to Mycobacterium ulcerans.

Diana Diaz1, Heinz Döbeli, Dorothy Yeboah-Manu, Ernestina Mensah-Quainoo, Arno Friedlein, Nicole Soder, Simona Rondini, Thomas Bodmer, Gerd Pluschke.   

Abstract

While it is well established that proximity to wetlands is a risk factor for contracting Buruli ulcer, it is not clear what proportion of a population living in an area where the etiologic agent, Mycobacterium ulcerans, is endemic is actually exposed to this disease. Immunological cross-reactivity among mycobacterial species complicates the development of a specific serological test. Among immunodominant proteins recognized by a panel of anti-M. ulcerans monoclonal antibodies, the M. ulcerans homologue of the M. leprae 18-kDa small heat shock protein (shsp) was identified. Since this shsp has no homologues in M. bovis and M. tuberculosis, we evaluated its use as a target antigen for a serological test. Anti-18-kDa shsp antibodies were frequently found in the sera of Buruli ulcer patients and of healthy household contacts but rarely found in controls from regions where the infection is not endemic. The results indicate that only a small proportion of M. ulcerans-infected individuals contract the clinical disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021247      PMCID: PMC1694454          DOI: 10.1128/CVI.00254-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  41 in total

1.  Disseminated Mycobacterium ulcerans disease in an HIV-positive patient: a case study.

Authors:  R Christian Johnson; David Ifebe; Aristote Hans-Moevi; Luc Kestens; Raoul Houessou; Augustin Guédénon; Wayne M Meyers; Françoise Portaels
Journal:  AIDS       Date:  2002-08-16       Impact factor: 4.177

2.  A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells.

Authors:  K M George; L Pascopella; D M Welty; P L Small
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Massive gene decay in the leprosy bacillus.

Authors:  S T Cole; K Eiglmeier; J Parkhill; K D James; N R Thomson; P R Wheeler; N Honoré; T Garnier; C Churcher; D Harris; K Mungall; D Basham; D Brown; T Chillingworth; R Connor; R M Davies; K Devlin; S Duthoy; T Feltwell; A Fraser; N Hamlin; S Holroyd; T Hornsby; K Jagels; C Lacroix; J Maclean; S Moule; L Murphy; K Oliver; M A Quail; M A Rajandream; K M Rutherford; S Rutter; K Seeger; S Simon; M Simmonds; J Skelton; R Squares; S Squares; K Stevens; K Taylor; S Whitehead; J R Woodward; B G Barrell
Journal:  Nature       Date:  2001-02-22       Impact factor: 49.962

4.  Acquired T-helper 1 lymphocyte anergy following infection with Mycobacterium ulcerans.

Authors:  Travis M Gooding; Andrew S Kemp; Roy M Robins-Browne; May Smith; Paul D R Johnson
Journal:  Clin Infect Dis       Date:  2003-04-03       Impact factor: 9.079

5.  Mycobacterium ulcerans cytotoxicity in an adipose cell model.

Authors:  K M Dobos; P L Small; M Deslauriers; F D Quinn; C H King
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Identification of Mycobacterium ulcerans in the environment from regions in Southeast Australia in which it is endemic with sequence capture-PCR.

Authors:  T Stinear; J K Davies; G A Jenkin; J A Hayman; F Oppedisano; P D Johnson
Journal:  Appl Environ Microbiol       Date:  2000-08       Impact factor: 4.792

7.  Cross-reactive epitopes and HLA-restriction elements in human T cell recognition of the Mycobacterium leprae 18-kD heat shock protein.

Authors:  A S Mustafa; K E Lundin; R H Meloen; F Oftung
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

8.  Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens?

Authors:  Sayera Banu; Nadine Honoré; Brigitte Saint-Joanis; Dana Philpott; Marie-Christine Prévost; Stewart T Cole
Journal:  Mol Microbiol       Date:  2002-04       Impact factor: 3.501

9.  Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts.

Authors:  Travis M Gooding; Paul D R Johnson; May Smith; Andrew S Kemp; Roy M Robins-Browne
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Aquatic insects as a vector for Mycobacterium ulcerans.

Authors:  Laurent Marsollier; Raymond Robert; Jacques Aubry; Jean-Paul Saint André; Henri Kouakou; Pierre Legras; Anne-Lise Manceau; Chetaou Mahaza; Bernard Carbonnelle
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

View more
  32 in total

1.  Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model.

Authors:  Marie-Thérèse Ruf; Daniela Schütte; Aurélie Chauffour; Vincent Jarlier; Baohong Ji; Gerd Pluschke
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.

Authors:  Alexandra G Fraga; Andrea Cruz; Teresa G Martins; Egídio Torrado; Margarida Saraiva; Daniela R Pereira; Wayne M Meyers; Françoise Portaels; Manuel T Silva; António G Castro; Jorge Pedrosa
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Optimized method for preparation of DNA from pathogenic and environmental mycobacteria.

Authors:  Michael Käser; Marie-Thérèse Ruf; Julia Hauser; Laurent Marsollier; Gerd Pluschke
Journal:  Appl Environ Microbiol       Date:  2008-12-01       Impact factor: 4.792

4.  Spontaneous clearance of Mycobacterium ulcerans in a case of Buruli ulcer.

Authors:  Claire L Gordon; John A Buntine; John A Hayman; Caroline J Lavender; Janet A Fyfe; Patrick Hosking; Paul D R Johnson
Journal:  PLoS Negl Trop Dis       Date:  2011-10-25

Review 5.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

6.  In Vivo Imaging of Bioluminescent Mycobacterium ulcerans: A Tool to Refine the Murine Buruli Ulcer Tail Model.

Authors:  Till F Omansen; Renee A Marcsisin; Brendon Y Chua; Weiguang Zeng; David C Jackson; Jessica L Porter; Ymkje Stienstra; Tjip S van der Werf; Timothy P Stinear
Journal:  Am J Trop Med Hyg       Date:  2019-12       Impact factor: 2.345

Review 7.  Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Authors:  Caroline Demangel; Timothy P Stinear; Stewart T Cole
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

8.  Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics.

Authors:  Sacha J Pidot; Jessica L Porter; Laurent Marsollier; Annick Chauty; Florence Migot-Nabias; Cyril Badaut; Angèle Bénard; Marie-Therese Ruf; Torsten Seemann; Paul D R Johnson; John K Davies; Grant A Jenkin; Gerd Pluschke; Timothy P Stinear
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

Review 9.  Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease.

Authors:  Jeannette Guarner
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

Review 10.  Buruli ulcer disease: prospects for a vaccine.

Authors:  Kris Huygen; Ohene Adjei; Dissou Affolabi; Gisela Bretzel; Caroline Demangel; Bernhard Fleischer; Roch Christian Johnson; Jorge Pedrosa; Delphin M Phanzu; Richard O Phillips; Gerd Pluschke; Vera Siegmund; Mahavir Singh; Tjip S van der Werf; Mark Wansbrough-Jones; Françoise Portaels
Journal:  Med Microbiol Immunol       Date:  2009-02-07       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.